Company No: 10685524 (England and Wales)

Contents

• Balance Sheet
• Notes to the Financial Statements

	Note	2026		2025
		£		£
Fixed assets
Intangible assets	3	4,251		5,668
Tangible assets	4	36,446		47,934
		40,697		53,602
Current assets
Debtors	5	50,890		147,234
Cash at bank and in hand	6	168,464		152,119
		219,354		299,353
Creditors: amounts falling due within one year	7	( 45,090)		( 50,074)
Net current assets		174,264		249,279
Total assets less current liabilities		214,961		302,881
Net assets		214,961		302,881
Capital and reserves
Called-up share capital	8	37		37
Share premium account		1,492,918		1,492,918
Profit and loss account		( 1,277,994 )		( 1,190,074 )
Total shareholders' funds		214,961		302,881

For the financial year ending 31 March 2026 the Company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:

• The members have not required the Company to obtain an audit of its financial statements for the financial year in accordance with section 476;
• The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements; and
• These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime and a copy of the Profit and Loss Account has not been delivered.

The financial statements of Renovos Biologics Limited (registered number: 10685524) were approved and authorised for issue by the Board of Directors. They were signed on its behalf by:

J A Otter Director

22 July 2026

1. Accounting policies

The principal accounting policies are summarised below. They have all been applied consistently throughout the financial year and to the preceding financial year, unless otherwise stated.

General information and basis of accounting

Renovos Biologics Limited (the Company) is a private company, limited by shares, incorporated in the United Kingdom under the Companies Act 2006 and is registered in England and Wales. The address of the Company's registered office is 2 Venture Road Southampton Science Park, Chilworth, Southampton, SO16 7NP, United Kingdom.

The financial statements have been prepared under the historical cost convention, modified to include certain items at fair value, and in accordance with Section 1A of Financial Reporting Standard 102 (FRS 102) ‘The Financial Reporting Standard applicable in the UK and Republic of Ireland’ issued by the Financial Reporting Council and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime.

The financial statements are presented in pounds sterling which is the functional currency of the Company and rounded to the nearest £.

Foreign currency

Transactions in foreign currencies are recorded at the rate of exchange at the date of the transaction. Monetary assets and liabilities denominated in foreign currencies at the Balance Sheet date are reported at the rates of exchange prevailing at that date.

Exchange differences are recognised in the Profit and Loss Account in the period in which they arise except for exchange differences arising on gains or losses on non-monetary items which are recognised in the Statement of Comprehensive Income.

Employee benefits

Defined contribution schemes
The Company operates a defined contribution scheme. The amount charged to the Profit and Loss Account in respect of pension costs and other post-retirement benefits is the contributions payable in the financial year. Differences between contributions payable in the financial year and contributions actually paid are included as either accruals or prepayments in the Balance Sheet.

Taxation

Current tax
Current tax is provided at amounts expected to be paid (or recoverable) using the tax rates and laws that have been enacted or substantively enacted at the Balance Sheet date.

Intangible assets

Intangible assets are stated at cost or valuation, net of amortisation and any provision for impairment. Amortisation is provided on all intangible assets at rates to write off the cost or valuation of each asset over its expected useful life as follows:

Trademarks, patents and licences

10 years straight line

Tangible fixed assets

Tangible fixed assets are stated at cost or valuation, net of depreciation and any provision for impairment. Depreciation is provided on all tangible fixed assets, other than investment property and freehold land, at rates calculated to write off the cost or valuation, less estimated residual value, of each asset on a straight-line or reducing balance basis over its expected useful life, as follows:

Office equipment	5 years straight line
Computer equipment	5 years straight line
Other property, plant and equipment	5 years straight line

Residual value represents the estimated amount which would currently be obtained from disposal of an asset, after deducting estimated costs of disposal, if the asset were already of the age and in the condition expected at the end of its useful life.

The gain or loss arising on the disposal of an asset is determined as the difference between the sale proceeds and the carrying value of the asset, and is credited or charged to profit or loss.

Leases

The Company as lessee
Rentals under operating leases are charged on a straight-line basis over the lease term, even if the payments are not made on such a basis. Benefits received and receivable as an incentive to sign an operating lease are similarly spread on a straight-line basis over the lease term.

Cash and cash equivalents

Cash and cash equivalents are basic financial assets and include cash in hand, deposits held at call with banks, other short-term liquid investments with original maturities of three months or less, and bank overdrafts. Bank overdrafts are shown within borrowings in creditors: amounts falling due within one year.

Government grants

Government grants are recognised based on the accrual model and are measured at the fair value of the asset received or receivable. Grants are classified as relating either to revenue or to assets. Grants relating to revenue are recognised in income over the period in which the related costs are recognised. Grants relating to assets are recognised over the expected useful life of the asset. Where part of a grant relating to an asset is deferred, it is recognised as deferred income.

2. Employees

	2026		2025
	Number		Number
Monthly average number of persons employed by the Company during the year, including directors	6		7

3. Intangible assets

	Trademarks, patents and licences		Total
	£		£
Cost
At 01 April 2025	14,170		14,170
At 31 March 2026	14,170		14,170
Accumulated amortisation
At 01 April 2025	8,502		8,502
Charge for the financial year	1,417		1,417
At 31 March 2026	9,919		9,919
Net book value
At 31 March 2026	4,251		4,251
At 31 March 2025	5,668		5,668

4. Tangible assets

	Office equipment		Computer equipment		Other property, plant and equipment		Total
	£		£		£		£
Cost
At 01 April 2025	1,208		2,786		107,882		111,876
At 31 March 2026	1,208		2,786		107,882		111,876
Accumulated depreciation
At 01 April 2025	99		1,303		62,540		63,942
Charge for the financial year	241		402		10,845		11,488
At 31 March 2026	340		1,705		73,385		75,430
Net book value
At 31 March 2026	868		1,081		34,497		36,446
At 31 March 2025	1,109		1,483		45,342		47,934

5. Debtors

	2026		2025
	£		£
Prepayments	2,535		2,534
VAT recoverable	547		4,202
Corporation tax	47,808		140,498
	50,890		147,234

6. Cash and cash equivalents

	2026		2025
	£		£
Cash at bank and in hand	168,464		152,119

7. Creditors: amounts falling due within one year

	2026		2025
	£		£
Trade creditors	9		940
Accruals	37,870		46,305
Other taxation and social security	4,572		0
Other creditors	2,639		2,829
	45,090		50,074

8. Called-up share capital

	2026		2025
	£		£
Allotted, called-up and fully-paid
368,072 Ordinary shares of £ 0.0001 each	37		37

9. Financial commitments

Commitments

	2026		2025
	£		£
Total future minimum lease payments under non-cancellable operating leases	8,442		1,809

Pensions

The Company operates a defined contribution pension scheme for the directors and employees. The assets of the scheme are held separately from those of the Company in an independently administered fund.

The Company operates a defined contributions pension scheme. The assets of the scheme are held separately from those of the Company in an independently fund. The pension cost charge represents contributions payable by the Company to the fund and amounted to £16,047 (2025: £11,017). Contributions totalling £2,636 (2025: £2,829) were payable to the fund at the balance sheet date and are included in other creditors.